Drug Shortage Report for AMIKACIN SULFATE INJECTION
Report ID | 129150 |
Drug Identification Number | 02486717 |
Brand name | AMIKACIN SULFATE INJECTION |
Common or Proper name | Amikacin Sulfate Injection |
Company Name | OMEGA LABORATORIES LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | AMIKACIN |
Strength(s) | 250MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 x 2mL vial / fiole |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-10-23 |
Estimated end date | 2021-04-06 |
Actual end date | 2021-04-12 |
Shortage status | Resolved |
Updated date | 2021-04-26 |
Company comments | Demand on the market. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 11177 HAMON MONTREAL, QUEBEC CANADA H3M 3E4 |
Company contact information | info@omegalaboratory.com - 1-800-363-0584 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-11-30 | English | Compare |
v2 | 2020-11-30 | French | Compare |
v3 | 2021-02-25 | English | Compare |
v4 | 2021-02-25 | French | Compare |
v5 | 2021-04-26 | English | Compare |
v6 | 2021-04-26 | French | Compare |
Showing 1 to 6 of 6